Smart Meter And Industrial IoT Tailwinds Will Fail To Support Current Expectations

Catalysts

About Silicon Laboratories

Silicon Laboratories develops mixed signal wireless chips and software for Internet of Things applications across industrial, commercial, smart home and medical end markets.

What are the underlying business or industry changes driving this perspective?

• The push for grid digitalization and near real time utility monitoring is already fueling smart meter demand. If utilities slow project rollouts or shift to alternative architectures, Silicon Labs could see a lower trajectory for industrial IoT revenue growth relative to current expectations, which would weigh on top line expansion and limit operating leverage.
• The company is concentrating heavily on its Series 2 and Series 3 wireless platforms, including a long term manufacturing expansion with GlobalFoundries in New York. If next generation products do not convert the current opportunity funnel into sustained, high volume programs, product mix could drift toward lower contribution parts and compress gross margin from recent 60% plus levels.
• Active wireless asset tracking is framed as an emerging, high potential category. If customers favor alternative technologies or integrated solutions from larger competitors, this opportunity might not scale meaningfully, which would cap incremental revenue streams that are often assumed to support earnings growth beyond the current ramps in meters, ESL and medical.
• Tools like Studio 6 and the Simplicity AI SDK are designed to shorten development cycles and attract new IoT designers. If adoption is slower than anticipated or competing ecosystems match these capabilities, the expected acceleration in design win velocity could fall short, limiting future revenue and margin contribution from associated software and tool driven stickiness.
• The company is leaning into higher margin industrial and medical applications, including continuous glucose monitoring that management views as a path to roughly 10% of revenue in the first half of next year. Any delays in program ramps, competitive design losses or regulatory or reimbursement shifts could restrain revenue growth and leave earnings sensitive to the current cost base and incentive structures.

Assumptions

This narrative explores a more pessimistic perspective on Silicon Laboratories compared to the consensus, based on a Fair Value that aligns with the bearish cohort of analysts. How have these above catalysts been quantified?

• The bearish analysts are assuming Silicon Laboratories's revenue will grow by 16.3% annually over the next 3 years.
• The bearish analysts assume that profit margins will increase from -8.3% today to 5.9% in 3 years time.
• The bearish analysts expect earnings to reach $72.3 million (and earnings per share of $2.18) by about February 2029, up from $-64.9 million today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as $85.0 million.
• In order for the above numbers to justify the price target of the more bearish analyst cohort, the company would need to trade at a PE ratio of 86.9x on those 2029 earnings, up from -103.0x today. This future PE is greater than the current PE for the US Semiconductor industry at 42.2x.
• The bearish analysts expect the number of shares outstanding to grow by 1.53% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 10.48%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

• Industrial and commercial IoT demand, including smart meters, building automation, lighting and access points, is currently supporting revenue of US$206 million in the September quarter with 24% year over year revenue growth and guidance that implies 25% year over year growth in Q4. If this broad-based demand persists over several years, it could support a higher revenue base than a bearish view assumes.
• Home & Life applications such as smart home automation and medical devices, including continuous glucose monitoring and other medical programs that management believes can reach around 10% of revenue in the first half of next year, may create a more resilient and diversified revenue mix that limits downside to both revenue and earnings.
• Gross margin performance, with non GAAP gross margin at 58% in Q3 and guidance for 62% to 64% in Q4 including a temporary benefit, together with management commentary about maintaining around 60% to 61% over the next few quarters, suggests the business may sustain higher profitability levels than a bearish thesis that expects pressured margins and weaker net income.
• Development tools such as Studio 6 and the Simplicity AI SDK, which aim to shorten development cycles and reduce barriers for new IoT designers, could increase design win activity and customer stickiness over time. This may support higher long term revenue and potentially better operating leverage and earnings than a scenario where these tools fail to gain traction.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The assumed bearish price target for Silicon Laboratories is $135.0, which represents up to two standard deviations below the consensus price target of $164.12. This valuation is based on what can be assumed as the expectations of Silicon Laboratories's future earnings growth, profit margins and other risk factors from analysts on the more bearish end of the spectrum.
  
• However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $231.0, and the most bearish reporting a price target of just $135.0.
  
• In order for you to agree with the more bearish analyst cohort, you'd need to believe that by 2029, revenues will be $1.2 billion, earnings will come to $72.3 million, and it would be trading on a PE ratio of 86.9x, assuming you use a discount rate of 10.5%.
  
• Given the current share price of $203.41, the analyst price target of $135.0 is 50.7% lower. Despite analysts expecting the underlying business to improve, they seem to believe the market's expectations are too high.
  
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.